This £125 eye cream has 'amazed' aestheticians with its ability to target crow's feet and hooded eyes
A £125 eye cream has 'amazed' aestheticians after it was found to help reduce the look of users' crow's feet and hooding in just five weeks.
Calecim is a smart skincare brand with a line of skincare products powered by the age-fighting prowess of stem cells. Their Eye Contour Lifting Cream, in particular, has gained much attention thanks to its ability to enhance volume and improve skin quality, thanks to its unique combination of clinically proven active ingredients.
Calecim Eye Contour Lifting Cream
Loved by beauty insiders and aestheticians alike, the Calecim Eye Contour Lifting Cream uses the power of stem cells to help firm, brighten, and lift with every swipe.
And while this all sounds great, the Eye Contour Lifting Cream has impressed in clinical trials. With five to seven weeks of use, users in the clinical trials found noticeable improvements in the firmness, discolouration and puffiness.
£125 Shop
Fine lines and folds are a natural part of ageing and can be the first to show on the fragile eye area as it's the area of the face with the least amount of sebaceous oil glands.
That combined with the fact the eye lid skin is four times thinner than the rest of the face, it's no wonder why many need a little help with maintaining eye shape and contour as we get older.
That's where the Calecim Eye Contour Lifting Cream has impressed with its patented technology that penetrates to the deepest layers of the skin to rejuvenate from the inside out.
The hero ingredient in the Eye Contour Lifting Cream is Calecim's patented PTT-6®. PTT-6®, is derived ethically from the cord lining of red deer and contains stem cells and exosomes, which have been scientifically validated.
It should be noted that the extraction of these stem cells is conducted under extreme ethical considerations with no harm to any animals.
The benefits are that it contains over 3,000 proteins, including growth factors, cytokines and exosomes that signal cells to regenerate.
Over time, this is proven to increase the production of collagen and elastin, therefore reducing crepiness and translucency by thickening both epidermal and dermal skin layers. In short, this is far from your bog-standard eye cream.
Other key active ingredients include caffeine extract, fruit acids and niacinamides, which all help achieve younger-looking skin by aiding in elasticity, reducing crepiness, and improving the look of tired eyes.
And while this all sounds great, the Eye Contour Lifting Cream has impressed in clinical trials too. With five to seven weeks of use, users in the clinical trials found noticeable improvements in the firmness, discolouration and puffiness.
Tons of Calecim shoppers seem to love this product too, including doctors. 'I am amazed I can already see a difference in texture, tone and pigment after 1 week of using the Eye Contour Lifting Cream! My eyes already look much fresher!' says one verified reviewer.
Another agreed, adding: 'I'm a fairly difficult to impress 50 year old hospital consultant. My medical training has left me skeptical of too good to be true claims made about serums and creams... BUT this particular eye serum made a noticeable difference in just a few applications'.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
27 minutes ago
- The Guardian
Monica Seles adapting to ‘new normal' after being diagnosed with neuromuscular disease
Monica Seles says she was diagnosed with myasthenia gravis – a neuromuscular autoimmune disease – three years ago. The nine-time grand slam singles champion says she first noticed symptoms of the disease while she was swinging her racket. 'I would be playing with some kids or family members, and I would miss a ball. I was like, 'Yeah, I see two balls.' These are obviously symptoms that you can't ignore,' Seles said. 'And, for me, this is when this journey started. And it took me quite some time to really absorb it, speak openly about it, because it's a difficult one. It affects my day-to-day life quite a lot.' Seles, who won her first major, the 1990 French Open, at the age of 16 and played her last match in 2003, said she was diagnosed with myasthenia gravis three years ago and is speaking publicly about it for the first time before this month's US Open to raise awareness of the condition. The National Institute of Neurological Disorders and Stroke calls it 'a chronic neuromuscular disease that causes weakness in the voluntary muscles' and 'most commonly impacts young adult women (under 40) and older men (over 60) but … can occur at any age, including childhood'. There is currently no known cure. The 51-year-old said she'd never heard of the condition until she was referred to a neurologist after noticing symptoms such as double vision and weakness in her arms – 'just blowing my hair out … became very difficult,' she said – and legs. 'When I got diagnosed, I was like, 'What?!'' said Seles. 'So this is where – I can't emphasize enough – I wish I had somebody like me speak up about it.' The disease can also cause difficulty in swallowing, speaking and affect facial expressions. It's been three decades since Seles returned to competition at the 1995 US Open, making it to the final, more than two years after she was stabbed at a tournament in Germany. 'The way they welcomed me … after my stabbing, I will never forget,' Seles said about the fans in New York. 'Those are the moments that stay with you.' Seles says she is learning to live a 'new normal' and characterized her health as another in a series of life steps that required adapting. 'I had to, in tennis terms, I guess, reset – hard reset – a few times. I call my first hard reset when I came to the US as a young 13-year-old [from Yugoslavia]. Didn't speak the language; left my family. It's a very tough time. Then, obviously, becoming a great player, it's a reset, too, because the fame, money, the attention, changes [everything], and it's hard as a 16-year-old to deal with all that. Then obviously my stabbing – I had to do a huge reset,' Seles said. 'And then, really, being diagnosed with myasthenia gravis: another reset. But one thing, as I tell kids that I mentor: 'You've got to always adjust. That ball is bouncing, and you've just got to adjust. And that's what I'm doing now.' Seles won nine grand slam singles titles during her playing career, with Wimbledon being the only major she missed out on, although she did reach the final in 1992. Her 178 weeks at No 1 is sixth all-time in WTA history.
BBC News
an hour ago
- BBC News
Wolverhampton adult social care tech trial shortlisted for award
A technology-led pilot project within adult social care in Wolverhampton has been nominated for an carers, social workers and partners in the city have been trialling fall- prevention technologies, smart sensors and virtual care calls in everyday social care practice, the council scheme has resulted in a shift from "traditional, reactive care models to a personalised, preventative digital care system", City of Wolverhampton Council government-funded project has been used with more than 170 residents who have given positive feedback, the council said. As a result, the council and the Royal Wolverhampton NHS Trust be shortlisted for a Health Service Journal (HSJ) WM5G Technology Enabled Care (TEC) trial has been rolled out by OneWolverhampton – a partnership between the council, the trust and other has been funded by the Department for Science, Innovation and Technology (DSIT) under the 5G Innovation Region patients who have used the system reported having increased independence and an improved quality of life, the council has also been sharing its work with others with the aim of other regions trialling it. 'They transform lives' Paula Brookfield, cabinet member for adults, said: "We're proud to be recognised for our work to embed digital care into the heart of our social care system."This shortlisting is testament to the dedication of our teams and the power of working together. "We've shown that when digital tools are thoughtfully integrated, they don't just support care, they transform lives."Stephanie Cartwright, chief community and partnerships officer for the trust and a OneWolverhampton Board member, said the nomination was "fantastic news" The trial is one of 245 projects and people shortlisted for an HSJ award, the council said, and the winners would be announced at a ceremony in London in November. Follow BBC Wolverhampton & Black Country on BBC Sounds, Facebook, X and Instagram.
Telegraph
an hour ago
- Telegraph
Britain loses 283,000 working days to strikes in half a year
Britain lost more than 280,000 working days to strikes in the first half of this year, new figures show. Data from the Office for National Statistics (ONS) found 283,000 work days were missed because of labour disputes between January and June. The figures come despite Sir Keir Starmer, the Prime Minister, giving inflation-busting pay rises to millions of public sector workers last year in the hope of ending industrial action for good. February and March were the worst months for walkouts, with 55,000 days lost in each month. There were 50,000 strike days in January, 48,000 in April, 37,000 in May and 38,000 in June, the statistics watchdog also found. The Guido Fawkes political blog estimated that the hundreds of thousands lost days were the equivalent to more than 1,073 years of lost work. The number of lost working days is down significantly from the first six months of 2023, when more than 1.7 million days were lost, and the first half of 2024, when there were 464,000 lost days. However, the 280,000 total is still higher than any year between 2016 to 2022, suggesting the pay deals offered by the Government have only been partially effective in stopping strikes. The figures do not account for strikes held at the end of July by resident doctors, formerly known as junior doctors, after the Government rejected their demands for a further pay rise of 26 per cent. Walkouts by resident doctors between 2022 and 2024 led to 1.5 million cancellations in the NHS and prompted Wes Streeting, the Health Secretary, to agree to a 28.7 per cent pay rise over three years. While Mr Streeting's pay deal ended that round of strikes, the BMA union subsequently disputed figures that had been set out by the NHS and went on to demand more money. NHS England said that fewer than a third of junior doctors turned out to strike in July, with turnout down by 7.5 per cent on the previous round of industrial action a year previously. The bin strikes in Birmingham by the trade union Unite are ongoing, and Unite has warned that the dispute could last until December after workers voted to continue industrial action. The strikes began in January after Unite claimed Birmingham city council told the bin workers they would face pay cuts of up to £8,000 – representing a quarter of wages for some workers. Talks have been held via Acas, the consolidation service, but the dispute remains deadlocked despite Labour urging Unite to call off the action and reach a deal.
